Your browser doesn't support javascript.
loading
Whole-genome analysis reveals unexpected dynamics of mutant subclone development in a patient with JAK2-V617F-positive chronic myeloid leukemia.
Sloma, Ivan; Mitjavila-Garcia, Maria Teresa; Feraud, Olivier; Griscelli, Frank; Oudrhiri, Noufissa; El Marsafy, Sanaa; Gobbo, Emilie; Divers, Dominique; Proust, Alexis; Smadja, David M; Desterke, Christophe; Carles, Annaick; Ma, Yusanna; Hirst, Martin; Marra, Marco A; Eaves, Connie J; Bennaceur-Griscelli, Annelise; Turhan, Ali G.
Afiliação
  • Sloma I; Institut National de la Santé et de la Recherche Médicale (INSERM) U935, Villejuif, France; Service d'Hématologie Biologique, Institut Federatif d'Hematologie Interpôle Paris Sud-IFHIPS (AP-HP) Kremlin Bicêtre, Paris, France; Université Paris-Sud, Faculté de Médecine Kremlin Bicêtre, and INSERM UMS
  • Mitjavila-Garcia MT; Institut National de la Santé et de la Recherche Médicale (INSERM) U935, Villejuif, France.
  • Feraud O; Institut National de la Santé et de la Recherche Médicale (INSERM) U935, Villejuif, France; Human Pluripotent Stem Cell Core Facility, ESTeam Paris Sud-INGESTEM, Villejuif, France.
  • Griscelli F; Institut National de la Santé et de la Recherche Médicale (INSERM) U935, Villejuif, France; Human Pluripotent Stem Cell Core Facility, ESTeam Paris Sud-INGESTEM, Villejuif, France; Université Paris Descartes, Sorbonne Paris Cité, Faculté des Sciences Pharmaceutiques et Biologiques, Paris, France.
  • Oudrhiri N; Institut National de la Santé et de la Recherche Médicale (INSERM) U935, Villejuif, France; Human Pluripotent Stem Cell Core Facility, ESTeam Paris Sud-INGESTEM, Villejuif, France.
  • El Marsafy S; Institut National de la Santé et de la Recherche Médicale (INSERM) U935, Villejuif, France; Human Pluripotent Stem Cell Core Facility, ESTeam Paris Sud-INGESTEM, Villejuif, France.
  • Gobbo E; Human Pluripotent Stem Cell Core Facility, ESTeam Paris Sud-INGESTEM, Villejuif, France.
  • Divers D; Human Pluripotent Stem Cell Core Facility, ESTeam Paris Sud-INGESTEM, Villejuif, France.
  • Proust A; Institut National de la Santé et de la Recherche Médicale (INSERM) U935, Villejuif, France.
  • Smadja DM; Université Paris Descartes, Sorbonne Paris Cité, Faculté des Sciences Pharmaceutiques et Biologiques, Paris, France; AP-HP, Hôpital Européen Georges Pompidou, Service d'Hématologie Biologique, Paris, France.
  • Desterke C; Université Paris-Sud, Faculté de Médecine Kremlin Bicêtre, and INSERM UMS 33, Villejuif, France.
  • Carles A; University of British Columbia, Centre for High-Throughput Biology and Department of Microbiology & Immunology, Vancouver, BC, Canada.
  • Ma Y; Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC, Canada.
  • Hirst M; University of British Columbia, Centre for High-Throughput Biology and Department of Microbiology & Immunology, Vancouver, BC, Canada; Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC, Canada.
  • Marra MA; Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC, Canada; Terry Fox Laboratory, BC Cancer Agency, Vancouver, BC, Canada.
  • Eaves CJ; Terry Fox Laboratory, BC Cancer Agency, Vancouver, BC, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
  • Bennaceur-Griscelli A; Institut National de la Santé et de la Recherche Médicale (INSERM) U935, Villejuif, France; Service d'Hématologie Biologique, Institut Federatif d'Hematologie Interpôle Paris Sud-IFHIPS (AP-HP) Kremlin Bicêtre, Paris, France; Université Paris-Sud, Faculté de Médecine Kremlin Bicêtre, and INSERM UMS
  • Turhan AG; Institut National de la Santé et de la Recherche Médicale (INSERM) U935, Villejuif, France; Service d'Hématologie Biologique, Institut Federatif d'Hematologie Interpôle Paris Sud-IFHIPS (AP-HP) Kremlin Bicêtre, Paris, France; Université Paris-Sud, Faculté de Médecine Kremlin Bicêtre, and INSERM UMS
Exp Hematol ; 53: 48-58, 2017 09.
Article em En | MEDLINE | ID: mdl-28602946
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Janus Quinase 2 / Mutação Tipo de estudo: Prognostic_studies Limite: Humans / Male / Middle aged Idioma: En Revista: Exp Hematol Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Janus Quinase 2 / Mutação Tipo de estudo: Prognostic_studies Limite: Humans / Male / Middle aged Idioma: En Revista: Exp Hematol Ano de publicação: 2017 Tipo de documento: Article